Shire Settles Generic Adderall Spat With Sandoz
Irish drugmaker Shire PLC said Tuesday it had settled patent litigation over Sandoz Inc.'s abbreviated new drug application to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall...To view the full article, register now.
Already a subscriber? Click here to view full article